Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 792.00
+27.00 (3.53%)
Aug 14, 2025, 1:30 PM CST
TPE:6472 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 21,319 | 19,246 | 14,200 | 10,494 | 4,900 | 1,800 | Upgrade
|
| Revenue Growth (YoY) | 50.49% | 35.53% | 35.31% | 114.18% | 172.28% | 17.68% | Upgrade
|
| Cost of Revenue | 13,173 | 11,536 | 7,209 | 7,582 | 3,228 | 1,096 | Upgrade
|
| Gross Profit | 8,146 | 7,710 | 6,991 | 2,913 | 1,672 | 703.88 | Upgrade
|
| Selling, General & Admin | 4,107 | 3,633 | 1,444 | 861.52 | 584.52 | 441.16 | Upgrade
|
| Research & Development | 780.64 | 694.49 | 298.16 | 129.08 | 41.27 | 36.65 | Upgrade
|
| Operating Expenses | 4,887 | 4,328 | 1,742 | 990.6 | 625.79 | 477.81 | Upgrade
|
| Operating Income | 3,259 | 3,383 | 5,249 | 1,922 | 1,046 | 226.08 | Upgrade
|
| Interest Expense | -542.78 | -479.72 | -171.24 | -108.73 | -53.62 | -21.97 | Upgrade
|
| Interest & Investment Income | 91.42 | 91.42 | 62.95 | 11.36 | 0.22 | 0.96 | Upgrade
|
| Earnings From Equity Investments | -221.86 | -0.04 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 163.52 | 163.52 | -67.51 | 47.92 | -14.41 | -11.91 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,455 | 64.53 | 39.98 | 17.41 | 48.02 | 14.28 | Upgrade
|
| EBT Excluding Unusual Items | 4,204 | 3,222 | 5,113 | 1,890 | 1,026 | 207.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11.56 | 11.56 | -1,044 | -47.79 | - | 0.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | -27.99 | -27.99 | -5 | -2.36 | -2.24 | -0 | Upgrade
|
| Other Unusual Items | 1,749 | 1,749 | - | - | - | 387.86 | Upgrade
|
| Pretax Income | 5,937 | 4,955 | 4,064 | 1,840 | 1,024 | 595.4 | Upgrade
|
| Income Tax Expense | 750.73 | 914.58 | 992.23 | 438.48 | 274.23 | 16.97 | Upgrade
|
| Earnings From Continuing Operations | 5,186 | 4,040 | 3,072 | 1,402 | 749.74 | 578.43 | Upgrade
|
| Minority Interest in Earnings | -60.03 | -101.39 | -41.78 | -9.61 | - | - | Upgrade
|
| Net Income | 4,153 | 3,939 | 3,030 | 1,392 | 749.74 | 578.43 | Upgrade
|
| Net Income to Common | 4,153 | 3,939 | 3,030 | 1,392 | 749.74 | 578.43 | Upgrade
|
| Net Income Growth | 30.34% | 29.99% | 117.70% | 85.65% | 29.62% | 89.63% | Upgrade
|
| Shares Outstanding (Basic) | 124 | 122 | 120 | 117 | 116 | 115 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 134 | 124 | 118 | 117 | 116 | Upgrade
|
| Shares Change (YoY) | 8.69% | 8.17% | 4.93% | 1.41% | 0.86% | 7.55% | Upgrade
|
| EPS (Basic) | 33.61 | 32.25 | 25.17 | 11.89 | 6.44 | 5.03 | Upgrade
|
| EPS (Diluted) | 30.85 | 29.86 | 24.50 | 11.78 | 6.42 | 5.00 | Upgrade
|
| EPS Growth | 21.12% | 21.90% | 107.94% | 83.40% | 28.53% | 76.28% | Upgrade
|
| Free Cash Flow | 3,838 | 452.71 | 4,316 | 1,815 | 1,073 | 28.56 | Upgrade
|
| Free Cash Flow Per Share | 28.00 | 3.37 | 34.74 | 15.33 | 9.19 | 0.25 | Upgrade
|
| Dividend Per Share | - | 11.669 | 10.002 | 5.133 | 2.041 | 0.936 | Upgrade
|
| Dividend Growth | - | 16.67% | 94.84% | 151.53% | 118.14% | 30.00% | Upgrade
|
| Gross Margin | 38.21% | 40.06% | 49.23% | 27.76% | 34.12% | 39.11% | Upgrade
|
| Operating Margin | 15.29% | 17.58% | 36.97% | 18.32% | 21.35% | 12.56% | Upgrade
|
| Profit Margin | 19.48% | 20.47% | 21.34% | 13.26% | 15.30% | 32.14% | Upgrade
|
| Free Cash Flow Margin | 18.00% | 2.35% | 30.39% | 17.30% | 21.90% | 1.59% | Upgrade
|
| EBITDA | 4,231 | 4,240 | 5,734 | 2,169 | 1,211 | 354.25 | Upgrade
|
| EBITDA Margin | 19.84% | 22.03% | 40.38% | 20.67% | 24.72% | 19.68% | Upgrade
|
| D&A For EBITDA | 971.99 | 857.49 | 485.11 | 246.69 | 165.27 | 128.17 | Upgrade
|
| EBIT | 3,259 | 3,383 | 5,249 | 1,922 | 1,046 | 226.08 | Upgrade
|
| EBIT Margin | 15.29% | 17.58% | 36.97% | 18.32% | 21.35% | 12.56% | Upgrade
|
| Effective Tax Rate | 12.65% | 18.46% | 24.41% | 23.83% | 26.78% | 2.85% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.